Navigation Links
Amgen's BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Date:5/16/2012

ication of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, preclinical results do not guarantee safe and effective performance of product candidates in humans. The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models. The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures. Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of entering into such relationship. Also, we or others could identify safety, side effects or manufacturing problems with our products after they are on the market. Our business may be impacted by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.

In addition, sales of our products are affected by the reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment as well as U.S. legislation aff
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
2. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
3. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
4. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
5. Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
6. MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
7. Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
8. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
9. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
10. Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody
11. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Research and Markets  has announced the addition of ... report to their offering. The Global ... in-depth study on the current state of the global ... basic overview of the industry including definitions, classifications, applications ... is provided for the international markets including development trends, ...
(Date:8/27/2014)... Aug. 27, 2014 Decision Resources Group finds ... Memphis health system and hospital ... integration, with rivals Methodist Le Bonheur Healthcare and Baptist ... to coordinate patient care. In addition, a national contract ... most health plan enrollment in the Memphis ...
(Date:8/27/2014)... , August 27, 2014 ResearchMoz ... States  Laparoscopes Market Outlook to 2020. New report, ... market data on the United States Laparoscopes market ... dollars, volume (in units) and average prices (in US ... Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems ...
Breaking Medicine Technology:Global Pulse Oximeter Industry Report 2014 2Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... Saturday, August 20, veterinary cardiologists are going to the ... Heart Health Tour will stop with a soundproof medical ... Dog Park. (Photo:   http://photos.prnewswire.com/prnh/20110815/CG52446 ) ... veterinarians will be available to answer questions for dog ...
... 2011 For the first time, the U.S. ... clarifying how benefit-risk determinations are made during premarket ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Released today, the ... regulatory pathway for high-risk medical devices. The recommendations ...
Cached Medicine Technology:Free Dog Heart Health Screenings Available August 20 in Providence 2FDA Proposes Guidelines That Clarify Benefit-Risk Determinations for Medical Devices 2
(Date:8/27/2014)... report provides market analysis of “Military Laser Systems Market ... scanner, Laser Weapon, Dazzlers, Laser sights, Proximity Fuze, Ring ... (Aerospace, Defense and Homeland Security) - Forecast and Analysis ... application in the aerospace and defense market over next ... expected to register a CAGR of 4.23% to reach ...
(Date:8/27/2014)... BambooIndustry.com, an innovative company that provides many kinds of top ... are now offered on its website. In addition, the ... people that place an order for its newly released items ... off. , The company’s senior spokesman was excited to ... new and old customers can buy cheap bamboo panels on ...
(Date:8/27/2014)... DC (PRWEB) August 28, 2014 The ... Betty Pierce Dennis, DrPH, MN, RN, FAAN, became the ... Center for the Advancement of the Science of Nursing ... of seven that comprise the NLN Home for Transformative ... nation’s capital a year ago. , Under Dr. ...
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Broken Arrow, OK (PRWEB) August 27, 2014 ... provide their guests a comfortable bed to sleep without breaking ... in the market for a new foam mattress set for ... guests to sleep on, Bedding Mart has it all during ... , stock up on some of the best mattresses for ...
Breaking Medicine News(10 mins):Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2
... OWINGS MILLS, Md., July 23 Medifast, Inc. (NYSE: ... financial results for the period ended June 30, 2009 on Thursday, July 30, ... conference call and web cast to discuss the results on Thursday, July 30, ... parties can access the call by dialing (877) 407-0782 or (201) 689-8567, or ...
... July 23 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX) ... inhaled tobramycin nanoparticle (Zysolin(TM)) formulation was a more ... aeruginosa pneumonia when compared to inhaled and injected ... in an oral podium session at the 36th ...
... , , CHARLOTTE, N.C., July 23 MedCath Corporation (Nasdaq: ... to discuss results from its third quarter ended June 30, 2009. The company will issue a ... What: Third Quarter Earnings Conference ... 2009, How: Dial-in conference call, ...
... , , , ... reported results for the 2009 second quarter and first half ended June 30, ... second quarter and decreased 5% to $11.1 billion for the 2009 first half. ... for the 2009 second quarter and first half. , ...
... , , , ... DRAD ), today reported that stronger revenue from its Product (nuclear ... $784,000 in net profits and more than $3 million in positive cash ... , , Digirad CEO Todd Clyde said, ...
... ... eMindful is launching live, interactive yoga classes. As a special promotion eMindful is offering ... opportunity for anyone who has a yoga practice, or has wanted to explore the health ... ...
Cached Medicine News:Health News:Medifast, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday, July 30, 2009 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 3Health News:MedCath Corporation to Hold Conference Call on Third Quarter Results 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 3Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 4Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 5Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 6Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 7Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 8Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 9Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 10Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 11Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 12Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 13Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 14Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 15Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 16Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 2Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 3Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 4Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 5Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 6Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 7Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 2Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 3
For the quantitative determination of aspartate aminotransferase (AST) in human serum. The reagents are used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Liquid buffer and dry powder r...
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... 44 is an "assembly-line worker" for routine ... cytology laboratories. It automatically stains big quantities ... increased large number of reagent stations in ... a high throughput. Up to 12 baskets ...
Medicine Products: